Instead, it may help your provider understand your metabolic predispositions and tailor treatment selection and dosing strategy more precisely
Glycemic Control: Investigations include changes in fasting glucose, post-prandial responses, and HbA1c in metabolic-disease cohorts
Initial lab test: $75$100 if required, not included in membership Injectable GLP-1s: Compounded semaglutide: $199/month with 12-month commitment $249/month with 6-month commitment $299/month with 3-month commitment Liraglutide: $299/month with 12-month commitment Wegovy: $599/month with 6-month commitment $649/month with 3-month commitment Ozempic : $1799/month Mounjaro : $1899/month Zepbound: $1899/month Oral non-GLP-1 weight-loss medication: naltrexone + bupropion, with added options like metformin or topiramate: $69/month, available only as part of a 10-month prepaid plan How Hers compares: Found starts at $99/month and offers compounded medications as well as lifestyle coaching
These drugs effectively reduce blood sugar and energy intake by mimicking a naturally produced incretin hormone (GLP-1) that is released by the gut after eating
The 8 mg group was tracking close behind at approximately 13-15%
To further explore whether the effect of GLP-1R-based agonists on MASLD depends on their weight-loss effect, we performed UVMR and MVMR to identify the risk factor whose effect on MASLD is independent of BMI
